Terry J. Rosen, Chief Executive Officer at Arcus Biosciences, Inc. (RCUS), sold 16,347 shares at $20.72 ($350K) on 2022-06-16, disclosed to the SEC on 2022-06-21.
Seasonal sale ($350k) by Chief Executive Officer — this insider has traded RCUS in June in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.72 | 4,241 | $88K | 25.1% |
| 2 | $20.72 | 4,241 | $88K | 25.1% |
| 3 | $21.71 | 1,361 | $30K | 8.4% |
| 4 | $22.29 | 3,252 | $72K | 20.7% |
| 5 | $22.29 | 3,252 | $72K | 20.7% |
| Total | $21.43 avg | 16,347 |
| $350K |
| 100% |
| Filing → |
| RCUS | SELL | 2022-12-16 | $802K | — | Filing → |
| RCUS | SELL | 2021-12-20 | $277K | — | Filing → |
| RCUS | SELL | 2021-06-21 | $418K | — | Filing → |